Cleavage of GSDMD promotes IL-1β release without affecting its maturation, and it indirectly activates NF-ĸB signalling pathway and the subsequent recruitment of hepatic macrophages for inflammatory development, thereby affecting NASH [37,38]. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatohepatitis.